Reuters2021-07-09
July 9 (Reuters) - Cigarette maker Philip Morris International Inc said on Friday it will buy Vectura Group in a deal valuing the British pharmaceutical company at 1.05 billion pounds ($1.44 billion).
Shareholders of Vectura, which focuses on inhaled medicines, will get 150 pence per share in cash, U.S.-based Philip Morris said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email：uservice@ttm.financial